Skip to content

Effect of Modified Opioid Sparing Anesthesia on the Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery

Effect of Modified Opioid Sparing Anesthesia on the Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery - MOSA trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078806
Enrollment
Unknown
Registered
2023-12-19
Start date
2023-12-19
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic bariatric surgery

Interventions

Intervention group(MOSA group):Administering the modified opioid sparing anesthesia (MOSA) to patients: Intravenous pump dexmedetomidine 0.5ug/kg, after 10 minutes of pumping, Anesthesia was induced b
Control group(OBA group):Opioid based anesthesia (OBA) will be induced by intravenous injection of midazolam 2mg, dexamethasone 0.1mg/kg, propofol 1.5-2.5 mg/kg, sufentanil 0.4ug/kg and vecuronium 0.1

Sponsors

Yan 'an Hospital of Kunming City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1Adult (18 years or older) patients admitted to this study. 2Undergoing a scheduled laparoscopic bariatric surgery[Roux-en-Y gastric bypass(LRYGB) and sleeve gastrectomy(SG)]. 3ASA class ?-?. 4Having signed an informed consent.

Exclusion criteria

Exclusion criteria: 1. Current pregnancy or breastfeeding. 2. Patients with contraindications or allergies to the use of drugs such as esketamine, dexmedetomidine and lidocaine. 3. Severe mental illness such as schizophrenia, depression and dementia. 4. History of abuse of alcohol, opioids or other psychotropic drugs. 5. Patients unable to cooperate with the study for any reason, such as language comprehension disorder, hearing impairment or mental illness. 6. Preoperative planned intensive care unit (ICU) admission. 7. Individuals already participating in other studies.

Design outcomes

Primary

MeasureTime frame
The primary outcome is the quality of postoperative recovery according to the QoR-15 questionnaire scores on postoperative day 1 (POD1);

Secondary

MeasureTime frame
The QoR-15 score on postoperative day 2 (POD2).;The amount of drinking water of patients in 24h and 48h, the time to first flatus,and first defecation;Postoperative patient comfort and satisfaction in 24h,48h after surgery;Postoperative pain intensity on the NRS values in 24h,48h after surgery;The incidence and severity of postoperative nausea and vomiting (PONV);Intraoperative and postoperative opioid consumption (morphine equivalent);The anxiety and depression status of patients ;Length of hospital stay;Blood gas analysis was performed preoperatively, intraoperatively and postoperatively;

Countries

China

Contacts

Public ContactLi Shikuo

Yan 'an Hospital of Kunming City

kuoyu88@163.com+86 151 9880 9421

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026